{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:03:41Z","timestamp":1761581021163,"version":"build-2065373602"},"reference-count":14,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.clgc.2012.06.006","type":"journal-article","created":{"date-parts":[[2012,9,13]],"date-time":"2012-09-13T03:16:52Z","timestamp":1347506212000},"page":"66-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["False Positive 2-18Fluroro-deoxy-D-Glucose Positron Emission Tomography (FDG-PET) in Patients With Disseminated Seminoma and Post-Chemotherapy Residual Masses"],"prefix":"10.1016","volume":"11","author":[{"given":"Mathilde","family":"Wagner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joaquim","family":"Bellmunt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celine","family":"Boutros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald","family":"Bonardel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohann","family":"Loriot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"Albiges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Massard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karim","family":"Fizazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2012.06.006_bib1","first-page":"242s","article-title":"A risk-adapted study of cisplatin and etoposide, with or without ifosfamide, in patients with metastatic seminoma: results of the GETUG S99 multicenter prospective study","volume":"27","author":"Fizazi","year":"2009","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/j.clgc.2012.06.006_bib2","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/cncr.11574","article-title":"Advanced seminoma\u2013treatment results and prognostic factors for survival after first-line, cisplatin-based chemotherapy and for patients with recurrent disease: a single-institution experience in 145 patients","volume":"98","author":"Gholam","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.clgc.2012.06.006_bib3","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0959-8049(97)00033-6","article-title":"Radiotherapy after chemotherapy for metastatic seminoma\u2013a diminishing role","volume":"33","author":"Duchesne","year":"1997","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clgc.2012.06.006_bib4","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1200\/JCO.1996.14.2.454","article-title":"Management of residual mass in advanced seminoma: results and recommendations from the Memorial Sloan-Kettering Cancer Center","volume":"14","author":"Puc","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clgc.2012.06.006_bib5","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1200\/JCO.1996.14.10.2884","article-title":"Optimal management of residual mass after chemotherapy in advanced seminoma: there is time for everything","volume":"14","author":"Culine","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clgc.2012.06.006_bib6","doi-asserted-by":"crossref","first-page":"3740","DOI":"10.1200\/JCO.2001.19.17.3740","article-title":"Predictive impact of 2-18fluoro-2-deoxy-D-glucose positron emission tomography for residual postchemotherapy masses in patients with bulky seminoma","volume":"19","author":"De Santis","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clgc.2012.06.006_bib7","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1200\/JCO.2004.07.188","article-title":"2-18fluoro-deoxy-D-glucose positron emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma: an update of the prospective multicentric SEMPET trial","volume":"22","author":"De Santis","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clgc.2012.06.006_bib8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/annonc\/mdr052","article-title":"2-1. fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial","volume":"23","author":"Bachner","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clgc.2012.06.006_bib9","article-title":"Stage I seminoma: can 18 fluorodeoxyglucose positron emission tomography (FDG-PET) predict occult dissemination?","volume":"233","author":"Fizazi","year":"2008","journal-title":"Proc Genitourinary Cancers Symposium"},{"key":"10.1016\/j.clgc.2012.06.006_bib10","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1470-2045(00)00257-6","article-title":"Clinical role of positron emission tomography in oncology","volume":"2","author":"Bomanji","year":"2001","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clgc.2012.06.006_bib11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00345-004-0403-2","article-title":"The role of positron emission tomography in germ cell cancer","volume":"22","author":"De Santis","year":"2004","journal-title":"World J Urol"},{"key":"10.1016\/j.clgc.2012.06.006_bib12","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1200\/JCO.1999.17.11.3457","article-title":"Positron emission tomography scans in the evaluation of postchemotherapy residual masses in patients with seminoma","volume":"17","author":"Ganjoo","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clgc.2012.06.006_bib13","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.juro.2007.10.054","article-title":"The role of positron emission tomography in the evaluation of residual masses after chemotherapy for advanced stage seminoma","volume":"179","author":"Hinz","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.clgc.2012.06.006_bib14","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1200\/JCO.1996.14.5.1637","article-title":"Positron emission tomography evaluation of residual radiographic abnormalities in postchemotherapy germ cell tumor patients","volume":"14","author":"Stephens","year":"1996","journal-title":"J Clin Oncol"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767312001693?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767312001693?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:22:23Z","timestamp":1761564143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767312001693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S1558767312001693"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2012.06.006","relation":{},"ISSN":["1558-7673"],"issn-type":[{"type":"print","value":"1558-7673"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"False Positive 2-18Fluroro-deoxy-D-Glucose Positron Emission Tomography (FDG-PET) in Patients With Disseminated Seminoma and Post-Chemotherapy Residual Masses","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2012.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}